FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Switzerland (CH)
Overview
Projects
(57)
Publications
(4,915)
External partners
(433)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 2-year efficacy and safety results from the phase 3 randomised, double-blind, placebo-controlled trial FUTURE 1 (2017)
Rech J, Reinhardt M, Kavanaugh A, Geusens P, Mpofu S
Conference contribution
Long Noncoding RNA H19X Is a Key Regulator of Apoptosis and Proliferation of Fibroblasts in Systemic Sclerosis and Other TGF beta-riven Fibrotic Diseases (2017)
Pachera E, Wunderlin A, Assassi S, Salazar G, Bertoncelj MF, Dobrota R, Brock M, et al.
Conference contribution
PREDICTION OF PROGRESSIVE SKIN THICKENING IN EARLY DIFFUSE SYSTEMIC SCLEROSIS USING THREE-MONTHLY SKIN SCORES FROM THE EUROPEAN SCLERODERMA OBSERVATIONAL STUDY (ESOS) (2017)
Herrick A, Peytrignet S, Pan X, Hesselstrand R, Mouthon L, Brown E, Czirjak L, et al.
Conference contribution
LONG NONCODING RNA H19X AS A NEW THERAPEUTIC TARGET FOR FIBROSIS (2017)
Pachera E, Wunderlin A, Assassi S, Salazar G, Frank-Bertoncelj M, Dobrota R, Brock M, et al.
Conference contribution
MICRORNA-125B AS A POTENTIAL FIBROTIC AND APOPTOTIC REGULATOR IN SYSTEMIC SCLEROSIS (2017)
Kozlova A, Pachera E, Renoux F, Rudnik M, Maurer B, Juengel A, Distler J, et al.
Conference contribution
OPEN-LABEL, MULTICENTER, DOSE-ESCALATING PHASE II CLINICAL TRIAL ON THE SAFETY AND EFFICACY OF TADEKINIG ALPHA IN ADULT ONSET STILL'S DISEASE (2017)
Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Koetter I, Hachulla E, et al.
Conference contribution
FRA2 OVEREXPRESSION LEADS TO SYSTEMIC AUTOIMMUNITY BY DECREASING IL-2 RESPONSIVENESS AND THYMIC TREG DEVELOPMENT (2017)
Renoux F, Stellato M, Impellizzieri D, Vogetseder A, Huang R, Subramaniam A, Dees C, et al.
Conference contribution
Fra-2 Overexpression Leads to Systemic Autoimmunity By Affecting IL2 Dependent Treg Homeostasis (2017)
Renoux F, Stellato M, Impellizzieri D, Vogetseder A, Blyszczuk P, Huang R, Subramaniam A, et al.
Conference contribution
EPIGENETIC REGULATION OF FRA2 BY JMJD3 REGULATES FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS (2017)
Bergmann C, Brandt A, Dees C, Wohlfahrt T, Zhang Y, Chen CW, Mallano T, et al.
Conference contribution
Current Practice of Anticoagulation for Pediatric VAD Therapy - A Multi-Institutional European Survey of the EXCOR Pediatric Investigator Group (EEPIG) (2017)
Miera O, Schmitt KR, Menon AK, Ersel S, Reiprich A, Akintuerk H, Thul J, et al.
Conference contribution
‹
1
...
334
335
336
337
338
...
492
›